Apoptosis-inducing factor (AIF) has important supportive as well as potentially lethal roles in neurons. Under normal physiological conditions, AIF is a vital redox-active mitochondrial enzyme, whereas in pathological situations, it translocates from mitochondria to the nuclei of injured neurons and mediates apoptotic chromatin condensation and cell death. In this study, we reveal the existence of a brain-specific isoform of AIF, AIF2, whose expression increases as neuronal precursor cells differentiate. AIF2 arises from the utilization of the alternative exon 2b, yet uses the same remaining 15 exons as the ubiquitous AIF1 isoform. AIF1 and AIF2 are similarly imported to mitochondria in which they anchor to the inner membrane facing the intermembrane space. However, the mitochondrial inner membrane sorting signal encoded in the exon 2b of AIF2 is more hydrophobic than that of AIF1, indicating a stronger membrane anchorage of AIF2 than AIF1. AIF2 is more difficult to be desorbed from mitochondria than AIF1 on exposure to non-ionic detergents or basic pH. Furthermore, AIF2 dimerizes with AIF1, thereby preventing its release from mitochondria. Conversely, it is conceivable that a neuron-specific AIF isoform, AIF2, may have been 'designed' to be retained in mitochondria and to minimize its potential neurotoxic activity. Apoptosis-inducing factor (AIF) has initially been described as a mitochondrial intermembrane protein that is released from mitochondria under conditions of cell death induction and that can induce isolated nuclei to undergo nuclear shrinkage and chromatinolysis, two features that are classically associated with apoptosis.
Apoptosis-inducing factor (AIF) has initially been described as a mitochondrial intermembrane protein that is released from mitochondria under conditions of cell death induction and that can induce isolated nuclei to undergo nuclear shrinkage and chromatinolysis, two features that are classically associated with apoptosis. 1 Since its discovery 10 years ago, the AIF protein has been characterized at the structural level, 2, 3 and the AIF gene has been subjected to genetic manipulations in mice, flies, nematodes and yeast, revealing the phylogenetically conserved contribution of AIF to cell death in multiple systems. 4, 5 After the mitochondrial import of the precursor AIF protein and the removal of its N-terminal 53 amino acids, which includes a mitochondrial localization sequence (MLS), the processed mature human AIF 62 kDa is inserted into the inner mitochondrial membrane, with the N-terminus facing the matrix and with the C-terminal catalytic domain exposed to the intermembrane space. 6 The mitochondrial AIF protein is an NAD(P)H oxidase 7 whose local redox function is essential for optimal oxidative phosphorylation. 8 Knockdown, deletion or hypomorphic mutation of AIF (the harlequin or Hq mutation) reduces the expression of complex I subunits in the respiratory chain, 8 thereby provoking a mitochondriopathy that leads to progressive neurodegeneration, photoreceptor loss and cardiomyopathy. [9] [10] [11] [12] [13] The consistent finding that the targeting of AIF mostly affects the central nervous system (CNS) 9 might either be explained by the general tendency of complex I mitochondriopathies to manifest at the level of the CNS 14 and/or by an implication of AIF in the differentiation of neuronal cell precursors. 12 On apoptotic stimuli, AIF, which is able to directly interact with DNA, 15 translocates to the nucleus and participates in chromatin condensation and chromatinolysis. 16 The switch from the vital to the lethal functions of AIF is spatially regulated by its subcellular localization and tightly controlled by at least two processes: (i) outer mitochondrial membrane permeabilization (MOMP), which is regulated by multiple mitochondrial proteins including members of the Bcl-2 family, 17 (ii) activation of a series of non-caspase cysteine proteases (including calpains and cathepsins) that cleave the N-terminal membrane insertion domain at amino acid 101, thus catalyzing the de-attachment of mature AIF from the inner mitochondrial membrane. 5, 6, 18 The nuclear translocation of AIF could be inhibited by the overexpression of heat shock protein 70, which can intercept AIF in the cytosol 19 or deletion of cyclophilin A, which is required for AIF to move into the nucleus. 20 In mice, the Hq mutation has been shown to reduce acute neuronal cell death after ischemia, hypoglycemia and neurotrauma in young animals, before they manifest the Hqassociated neurodegeneration. 21 However, the Hq mutation had no cardioprotective effect 13 and was not able to make islet beta cells more resistant to hydrogen peroxide-induced cell death, 22 suggesting that AIF contributes to lethal signaling in a cell type-specific manner.
Through alternative splicing, the precursor mRNA transcribed from the AIF gene can give rise to several distinct proteins. Thus, alternative utilization of the exons 2a or 2b of the AIF gene (16 exons in total) gives rise to AIF1 (the originally described isoform of AIF) or AIF2 (which has been found in cDNA libraries from fetal mouse tissues), respectively. AIF1 and AIF2 only differ in a short stretch of their amino acid sequence in the N-terminal region that is removed from the mature protein as it translocates to the nucleus. 23 Numerous functional studies have been performed on AIF1, the most abundant and ubiquitous AIF isoform, whereas, AIF2 has not been further characterized. In addition to the above mentioned isoforms, an alternate transcriptional start site located at intron 9 of AIF originates a short variant of the protein (AIFsh) that lacks the N-terminal MLS and the redoxactive domain, yet retains the nuclear localization sequence (NLS). The transfection-enforced overexpression of AIFsh results in a nuclear protein that causes apoptosis. 24 Moreover, another short form of AIF, AIFsh2, results from the alternative utilization of exon 9b (instead of 9), which contains a stop codon. AIFsh2 is a truncated protein that lacks the C-terminal pro-apoptotic domain, yet conserves its mitochondrial localization and redox function. 25 Both short AIF isoforms appear to be low-abundant in normal tissues because they have not been detected by immunoblot, with the exception of AIFsh2 that reportedly is present in the liver extracts. 24, 25 By characterizing the tissue expression profile of AIF isoforms, we discovered that AIF2 is specifically expressed in the CNS. Driven by the pathophysiological effect of AIF in neurodegeneration, 9, 11, 12 we performed an exhaustive functional and biochemical characterization of the AIF2 isoform and importantly, we found that, compared with AIF1, AIF2 possess a stronger anchoring capacity to the inner mitochondrial membrane. These results suggest that the neuronspecific AIF2 isoform has been 'designed' for maintaining its mitochondrial functions yet reducing its pro-apoptotic activities.
Results and Discussion
A novel brain-specific isoform of AIF, AIF2. When sequencing several cDNAs from fetal human brain, we detected an alternative exon 2 usage (Figure 1a) , indicating that the precursor of the human AIF mRNA can be alternatively spliced, yielding two isoforms that we designated AIF1 (when exon 2a is used) and AIF2 (when exon 2b is used). The alternative exons 2a and 2b are phylogenetically conserved among mammals. Similarly, the two exons were generated by gene duplication well before the speciation of mammals (data not shown). Indeed, we were able to trace the duplication event to chicken genome, in which a region homologous to the mammalian exon 2a can be found 5 0 of exon 2b on chromosome 4, although the splice acceptor site of exon 2a seems to be non-canonical (UCSC, genome browser). Thus, both exons 2a and 2b are detectable in published cDNA sequences from primates, rodents and other mammals (such as Equus caballus and Canis familiaris) (NCBI-Homologen database), whereas only one exon 2, which resembled exon 2b from mammals, could be discerned in chicken cDNA libraries (Figures 1b and c) . Amino acid alignments of exons 2a and 2b from several animal species revealed two positively charged and one negatively charged common residues, as well as conserved motifs with hydrophobic stretches (Figure 1c ). However, secondary structure predictions indicate the consequences of variable residues and their differential properties on the potential secondary structure of the segment encoded by each of the two exons ( Figure 1d ).
Quantitative expression profiling of the two AIF isoforms have shown that AIF2 mRNA was specifically detected in human brain, yet was absent from most other analyzed tissues except the retina (Figure 2a ). Within the human adult brain, AIF2 mRNA was found in all regions, including the cortex or in subcortical areas, and the expression level of AIF1 and AIF2 mRNAs were similar (Figure 2b ). This general expression profile was similar for all examined mouse tissues, in which AIF2 mRNA was again restricted to the brain (Figure 2c ). Both in human and mice, low levels of AIF expression were detected in the brain compared with other organs. This probably reflects the comparative paucity of mitochondria in the brain, because the ratio of AIF protein and the most abundant outer mitochondrial membrane protein, VDAC, is similar in a panel of distinct mouse organs including brain. 14 The expression levels of AIF1-and AIF2-specific mRNAs were equivalent in the adult mouse brain and were similarly affected by the hypomorphic Hq mutation that reduced the expression of both AIF1 and AIF2 to around 20% of the control level (Figure 2d ). It is noteworthy that the expression of human AIF2 mRNA was higher in adult brain than in fetal brain (while that of AIF1 was lower) (Figure 2b ), indicating that the AIF1/AIF2 ratio decreases as brain cells differentiate. Accordingly, mouse embryonic telencephalic cells immortalized with thermosensitive SV40 large T antigen (tsA58 LT-Ag) (Figures 3a and b) , or human embryonic mesencephalic cells immortalized with a v-Myc retroviral vector (Figure 3c ) could be stimulated to express higher AIF2 levels on in vitro differentiation. Thus, AIF2 is specifically and differentially expressed in brain cells, depending on their maturation status.
Next, we determined the relative AIF1 and AIF2 mRNA expression in the NCI (National Cancer Institute) panel of cancer cell lines (NCI60). Although AIF1 was expressed by all cells, independently of their tissue origin, AIF2 was absent from all samples (Supplementary Figure 1) , including from brain cancer cell lines, of glial origin, contained in the NCI panel ( Figure 4a ). However, AIF2 was expressed by a fraction of neuroblastomas (Figures 4a and b) , in line with the data obtained on normal, untransformed tissues (see above, Figure 2 ). In conclusion, AIF2 is specific for neuronal tissues and neuroblastomas.
Cellular and subcellular localization of AIF2. Comparative in situ hybridizations of the adult mouse brain with isoformspecific probes revealed a similar macroscopic distribution of AIF1 and AIF2 mRNAs, with peak intensities in the olfactory bulb, rostral migratory stream, olfactory cortex and pituitary (Figures 5a-f, negative controls with anti-sense probes are shown in Supplementary Figure 2) . To analyze whether both AIF isoforms are expressed in the same cells, we performed a simultaneous fluorescent in situ hybridization (FISH) with differentially labeled exon 2a-and 2b-specific probes (red and green, respectively). In most brain regions, AIF1 and AIF2 were co-expressed by the same cells. However, approximately 25% of the cells present in the anterior olfactory nucleus stained uniquely for the exon 2b-specific probe, indicating the existence of brain cells that solely express AIF2 (and not AIF1) (Figures 5g-i ).
AIF1 and AIF2 share an identical N-terminal MLS, while their exon 2-encoded inner membrane sorting signals (IMSS) differ (Figure 1 ). To analyze whether this difference might affect the mitochondrial localization of AIF2, we compared the subcellular distribution of AIF1 and AIF2 by transfecting Hela cells with Flag-tagged versions of AIF1 or AIF2 (with the Flag fused to the C-terminus). When transfected cells were fixed and permeabilized with paraformaldehyde plus Triton X100 and stained with a Flag-specific antibody (Figure 6a ), we found both proteins similarly redistributed into mitochondria Mutiple alignment of exon 2-encoded polypeptides, available from public databases, reveals a restricted simultaneous usage of exon 2a and 2b to mammals. Chicken AIF protein is rooted to mammalian AIF2. This tree is obtained using neighbor joining method after clustalW multiple alignment. Refseq identifiers for analyzed protein sequences are the followings: Homo sapiens AIF1 (NP_004199), AIF2 (NP_665811); Macaca mulata AIF1 (XP_001092146), AIF2 (XP_001092025); Equus Caballus AIF1 (XP_001915191), AIF2 (XP_001915198); Canis familiaris AIF1 (XP_538170), (AIF2 XP_865808); Mus musculus AIF1 (NP_036149), AIF2 (CAM22220); Rattus norvegicus AIF1 (NP_112646), AIF2 (EDM10916); Gallus gallus AIF (NP_001007491). (c) AIF1-IMSS and AIF2-IMSS share conserved amino acids. Multiple alignment of exon 2a-encoded against exon 2b-encoded polypeptide segments, from the same organisms presented in 1b, was achieved using clustalW multiple alignment program. Star indicates fully conserved residues. Dots indicate residues with similar properties. The histogram of residue conservation is presented at the bottom of the figure. (d) Prediction of secondary structural characteristics and physicochemical properties of the N-terminal segments of AIF1 and AIF2. Entire primary amino acid sequences of AIF1 and AIF2 were analyzed using DNASTAR Protean Secondary structure prediction program and only the result for the N-terminal segment (MLS þ IMSS) of each isoform is shown (which were labeled with a matrix-targeted fluorescent protein, dsRed-mito), with no discernible effects on the overall shape of the mitochondrial network. Differential permeabilization of the outer mitochondrial membrane (with 0.4 mg/ml digitonin) and the inner membrane (with 0.8 mg/ml digitonin) allowed antibodies specific for Tim23 (an inner membraneanchored protein) and cyclophilin D (a soluble matrix protein), respectively, to access mitochondria (Figure 6b ). In these conditions, a Flag-specific antibody gained access to AIF1 and AIF2 similarly, as soon as the outer mitochondrial membrane was permeabilized (Figures 6b and c) , in concordance with the notion that both proteins expose their flagged C-termini to the intermembrane space.
AIF-deficient cells show reduced abundance of complex I subunits, resulting in a severe respiratory dysfunction. 8 Accordingly, small interfering RNAs specific for exon 2a or the 3 0 UTR of AIF led to a marked reduction in the expression of the 20 kDa complex I subunit (CI SU20) ( Figure 6d ) and other complex I subunits (not shown) in U2OS cells (which only express AIF1). The transfection of AIF2 (whose expression is not impeded by either of the two siRNAs) blunted the depletion of CI SU20 induced by AIF1 knockdown, as much as did the transfection of AIF1 (whose overexpression is abolished by the exon 2a-specific siRNA, yet not affected by the 3 0 UTR-specific siRNA) ( Figure 6d ). These results corroborate the hypothesis that both AIF isoforms are localized in the same submitochondrial compartment in which they both sustain the biogenesis or stability of complex I from the respiratory chain. It should be noted that the respiratory and redox functions of AIF are closely linked because redoxdeficient AIF mutants are unable to restore the abundance and function of respiratory chain complex I from AIF knockout cell. 26 Therefore, it appears plausible that AIF2 has a normal redox function, similar to that of AIF1. Recently, Churbanova et al. 27 reported a rather low NAD(P)H oxidase activity for a recombinant AIF protein that resembles endogenous AIF more closely than a His-tagged, truncated protein that had been analyzed earlier. 7 In line with this possibility, we found that the siRNA-mediated depletion of AIF1 and/or AIF2 from SHSY-5Y neuroblastoma cells (which express both AIF1 and AIF2) did not affect cellular NAD(P)H levels (Supplementary Figure 3) .
Biochemical differences between AIF1 and AIF2. To detect further possible differences between AIF1 and AIF2, we stably transfected the Flag-tagged versions of both proteins in U2OS cells, obtaining supraphysiological levels of AIF1 and AIF2 (Supplementary Figure 4a) . Both Flagtagged AIF1 and AIF2 cDNAs led to the expression of proteins with a similar electrophoretic mobility corresponding to B65 kDa (Supplementary Figure 4a) , and similar comigration results were obtained for non-tagged versions of AIF1 and AIF2 (not shown). The overexpression of AIF1 or AIF2 had neither deleterious effect on the proliferation rate (not shown), nor affected the respiratory capacity and control of the cells (Supplementary Figure 4b) . However, both AIF isoforms differentially affected the ultrastructure of mitochondria, as detectable by transmission electron microscopy (TEM). AIF1 (but not AIF2) overexpression lead to a rarefaction of cristae, while AIF2 (but not AIF1) overexpression was achieved by standard curve method using an AIF1/AIF2 reference plasmid. For murine RNA samples, relative fold variation of AIF1 and AIF2 were calculated using the comparative C t method
Brain-specific AIF2 E Hangen et al tended to increase the curvature of cristae, which frequently adopted an onion-like shape (Supplementary Figure 4c) . Although this result was obtained in conditions in which the two AIF isoforms were overexpressed, it suggested subtle differences in the effect of the insertion of their putative transmembrane domains on mitochondrial membrane structure.
Driven by these results, we analyzed whether AIF1 and AIF2 actually differ in their membrane anchorage, in conditions in which Flag-tagged AIF1 and AIF2 are expressed at physiological levels (lower than endogenous AIF, Figures 7a  and b) . AIF1 versus AIF2-expressing cells were exposed to increasing concentrations of the non-ionic detergent Igepal CA-630, and the extractability of the two AIF isoforms was measured. While Igepal CA-630 efficiently extracted AIF1 from mitochondria, AIF2 was largely resistant to the detergent and remained bound to the ultracentrifugable pellet. Thus, AIF2 behaves like the inner membrane-anchored CI SU20, while AIF1 behaved like several soluble mitochondrial proteins including cytochrome c (Figure 7a) . When, the Igepal CA-630 extraction protocol was replaced by a different one involving sodium carbonate, Flag-tagged AIF1 was again released in conditions of basic pH (pH ¼ 10.5), whereas Flagtagged AIF2 remained attached to the membrane fraction (Figure 7b ). Importantly, in these conditions, endogenous AIF1 (the sole isoform of AIF expressed in HeLa cells) behaved like Flag-tagged AIF1, indicating that membraneanchoring properties of the recombinant AIF was not affected by the Flag tag ( Figure 7b ). Next, we assessed the effect of the alkylating agent MNNG on the release of AIF1 versus AIF2. Again, it appeared that Flag-tagged AIF1 was readily released into the cytosol of MNNG-treated cells, while Flag-tagged AIF2 remained attached to mitochondria (Figure 7c ). In these conditions, endogenous AIF1 co-translocated to the cytosol in the presence of Flag-tagged AIF1. However, endogenous AIF1 was withheld from the cytosol in the presence of Flagtagged AIF2 (Figure 7c) .
We conclude that AIF2 is more difficult to be released from mitochondria than AIF1. This difference cannot be explained by the consensus sequence of the cleavage site by calpains and cathepsins, which is the same for both proteins. Rather, the differential release of AIF1 and AIF2 must be linked to other properties of the molecules such as the accessibility of AIF2 to proteases. Thus, the N-terminus of AIF2 might be more profoundly 'buried' in the lipid bilayer of the inner mitochondrial membrane than that of AIF1. In support of this possibility, biochemical studies of AIF1 carried out by Churbanova et al. 27 suggest that redox-regulated changes in the conformation of AIF that implicate its N-terminal and C-terminal segments might dictate AIF's accessibility to apoptotic proteases and regulate its mitochondrial release in dying cells. In this context, the dimerization of AIF molecules has also been suggested. 27, 28 Indeed, endogenous AIF1 could be detected in the anti-Flag immunoprecipitate of Flagtagged AIF1 or AIF2 (Figure 7d) . Thus, the two AIF isoforms can form homo-or heterodimers or higher-order oligomers. Accordingly, we hypothesize that the inhibitory effect of AIF2 on AIF1 release might be explained by a physical interaction between the two isoforms that makes the mitochondrial release-associated cleavage of AIF1 more difficult to be achieved when AIF2 is present.
Concluding remarks. In this paper, we comparatively analyze two AIF isoforms that solely differ in the utilization of one exon (exon 2) that code for a portion of the AIF Nterminus. Both AIF isoforms, AIF1 and AIF2, are associated with the inner mitochondrial membrane and are similar in their capacity to sustain a normal function of the respiratory chain. Importantly, it appears that the IMSS of AIF1 (IMSS-AIF1), which is encoded by exon 2a, is cleaved during the import of the AIF precursor into mitochondria, in a highly conserved peptide motif, after residue 54 (in humans AIF1) or residue 53 (in mouse AIF). 6, 29 This implies that only 29 amino acids of the C-terminal half of IMSS-AIF1 are present in the mature mitochondrial AIF1 protein. Importantly, mature mitochondrial AIF2 (as present in brain tissues or obtained by transfection with a cDNA) showed exactly the same electrophoretic mobility as AIF1, suggesting that AIF2 is trimmed during mitochondrial import by a peptidase that cleaves within the exon 2b-encoded IMSS-AIF2 as well. As a result, the N-terminus of AIF1 and AIF2 are dissimilar in their primary sequence as well as in their hydrophobicity, explaining the relatively loose association of AIF1 (which bears a less hydrophobic N-terminus than AIF2) with the inner mitochondrial membrane. Consequently, AIF2 is more difficult to dissociate from mitochondrial membranes, irrespective of the nature of the desorbing agent (non-ionic detergents, basic pH or MNNG stimuli), suggesting that AIF2 contributes less efficiently to apoptosis than AIF1.
AIF2 was solely expressed in the developing and adult CNS, as well as in the retina (which contains neurons and, in developmental and anatomical terms, is a CNS derivative). Similarly, AIF2 was present in neuroblastomas but not in any other kind of tumor derived from non-neuronal tissues. Although all CNS cells that express AIF1 also contain AIF2, some cells whose exact nature remains to be identified are positive for AIF2 but not for AIF1. What might be the 'purpose' of CNS-restricted expression of AIF2 in teleological terms? AIF1 and AIF2 share their vital functions with regard to mitochondrial respiration, while AIF2 is more tightly bound to mitochondrial membranes and hence less likely to mediate cell death (which requires the mitochondrial release and nuclear translocation of AIF). If this hypothesis was correct, the utilization of exon 2b (which gives rise to AIF2) might constitute a strategy to avoid AIF-dependent neurotoxicity. As AIF1 and AIF2 can interact with each other and as AIF2 can withhold AIF1 in mitochondria, the putative neuroprotective function of AIF2 would extend to those cells that express both AIF1 and AIF2. For testing this hypothesis, exon 2b-specific knockouts should be generated and evaluated for their putative neurotoxicity alone or upon neuronal injury. As a caveat, it must be mentioned that the expression level of AIF has a profound effect on neuronal differentiation. 12 Therefore, it remains formally possible that AIF2 (but not AIF1) is intimately linked to CNS development and that the exon 2b-specific knockout will cause major brain defects. These intriguing hypotheses will be studied in the future. . aon, anterior olfactory nucleus; gl, glomerular layer; gro, granular cell layer; mi, mitral cell layer; tu, olfactory tubercle; pir, piriform cortex (PAA), 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA) and 0.01% bmercaptoethanol. Mouse neural precursor cells (ETNA) were cultured and differentiated in vitro according to Cozzolino et al. 30 LUHMES (Lund Human Mesencephalic neurons) that were derived by conditional immortalization of female human embryonic ventral mesencephalic cells and subsequent clonal selection, could be differentiated in the presence of GDNF into postmitotic neurons with a robust dopaminergic phenotype. 31 Briefly, LUHMES were cultured in poly-L-lysine (Sigma) and fibronectin (Sigma) (50 mg/ml)-coated culture flasks in proliferation medium, namely DMEM/F12 (Sigma) supplemented with 2 mM L-glutamine (Invitrogen), 1% N2 supplement, 25 mg/ml bFGF (R&D Systems GmbH, Wiesbaden-Nordenstadt, Germany) and 1% penicillin/streptomycin (Invitrogen). Cells were cultured at a density of 2 Â 10 6 and split every 4 or 5 days with proliferation medium changes every 3 days or at 80% confluence. For differentiation, cells were seeded in six-well plates at a density of 40.000 cells/ cm 2 in differentiation medium, namely DMEM/F12, 1% N2 supplement, 1 mg/ml tetracyclin (Sigma), 49 mg/ml dibutyryl-cAMP (R&D Systems) and 5 ng/ml GDNF (R&D Systems). Every day and up to 6 days after the onset of differentiation, six wells were pooled for RNA extraction.
Plasmid and siRNA transfections were performed using Lipofectamine-2000 reagent (Invitrogen) by following manufacturer's procedure. Pools of stably transfected U2OS cells expressing AIF1-Flag or AIF2-Flag were established by cotransfection with the plasmids described above and the pPuro plasmid (Clontech) followed by selection in the presence of 0.25 mg/ml of puromycin (Clontech) and 0.5 mg/ml of Geneticin (Invitrogen).
Cell lysates preparation, immunoprecipitation and western blot analyses. For whole extract preparation, cells were harvested, washed three times with ice-cold PBS (8.1 mM Na 2 HPO 4 , 135 mM NaCl, 1.5 mM KH 2 PO 4 , 2.7 mM KCl), lysed with 1% SDS, boiled, sonicated and stored at À80 1C. Proteins contained in the lysate were quantified (DC protein assay; BioRad Laboratories, Hercules, CA, USA) and resolved directly by SDS-PAGE (NUPAGE; Invitrogen) and then subjected to western blot analyses following manufacturer's instructions (Invitrogen). For immunoprecipitations, cells were lysed for 20 min at 4 1C in the following buffer: NetN-120 (20 mM Tris-HCl at pH 8.0, 120 mM NaCl, 1 mM EDTA, 0.5% Igepal CA 630) supplemented with protease (EDTA-free protease inhibitor tablets -Roche Diagnostics Indianapolis, IN, USA) and phosphatase (Phosphatase inhibitor tablets -Roche) inhibitors. After centrifugation (13 000 Â g for 10 min at 4 1C), the protein content in the lysates was quantified and used for immunoprecipitations. The following immunoprecipitation procedure was used: first protein G-Sepharose CL-4B beads (50 ml of a 50% slurry, GE Healthcare, Piscataway, CA, USA) were coated with 1 mg of the indicated antibody, by incubating for 2 h at 4 1C in 800 ml of binding buffer (20 mM Tris-HCl pH 8.0, 120 mM NaCl, 1 mM EDTA, 0.5% Igepal). Then, antibody-coated beads were washed three times in binding buffer and incubated for 2 h at 4 1C with 300 mg of cell lysate, in a final volume of 800 ml. Beads were finally washed four times with lysis buffer and coimmunoprecipitated proteins were released by boiling in SB (2% SDS, 10% glycerol, 62.5 mM Tris-HCl pH 6.8, 100 mM dithiothreitol), resolved by SDS-PAGE and then subjected to western blot analysis. For western blot analysis, SDS-PAGE-resolved proteins were transferred onto nitrocellulose membrane (Biorad). Membranes were blocked by incubating with 5% nonfat milk powder in TBST buffer (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.05% Tween 20) for 1 h, and then for further 16 h at 4 1C with the specified primary antibody diluted in the same incubation mixture supplemented with 0.02% Na-azide. The membrane was then washed three times in TBST buffer before incubation with a horseradish peroxidase-conjugated secondary antibody. Antibody binding was detected with the ECL þ chemiluminescence detection kit (GE Healthcare).
Indirect immunofluorescence analyses. Cells were fixed on coverslips for 30 min with 4% PFA/2% Sucrose/0.19% Picric acid, and then permeabilized for 5 min with Triton 0.2% at room temperature. Flag-tagged proteins were detected by incubation with an anti-Flag mAb (1 : 8000 dilution), followed by Alexa fluor 488-conjugated goat anti-mouse. We stained the DNA in the samples with 1 mM TOPRO3 (Invitrogen). Samples slides were then mounted using the reagent Fluoromont-G (Southern Biotech) and observed by confocal microscopy with a Leica TSC-SPE confocal microscope equipped with a Â 63/1.15 Olympus objective and a Leica Aplication Suite (LAS) software (Leica Microsystems, Wetzlar, Germany). For the submitochondrial localization of AIF2, pools of stably transfected U2OS cells overexpressing AIF1-Flag ou AIF2-Flag were first fixed for 30 min with 4% PFA/2% Sucrose/0.19% Picric acid then permeabilized for 5 min without or with 0.4 and 0.8 mg/ml of digitonin. Flag-tagged proteins were detected by incubation with an anti-Flag mAb (1 : 8000 dilution), followed by a Alexa fluor 488-conjugated goat anti-mouse. Anti-Tim23 mab and CypD mab were used for the detection of mitochondrial inner membrane and matrix respectively. DNA in the samples was stained with TOPRO3. Samples were then mounted and observed with a Leica TSC-SPE confocal microscope.
RNA isolation and gene expression analysis by quantitative realtime PCR (qRT-PCR). Total RNA purified from normal human organs or brain sub-regions were purchased from Clonetech. Total RNA from wild-type (wt) or harlequin (Hq) mutant mice organs were extracted using Precellys homogenizer (Bertin Technologies, Montigny-le-Bretonneux, France) and RNA isolation kit from Qiagen (Courtaboeuf, France). RNA from human and mouse cells in culture were extracted using PARIS kit (Ambion, Applied Biosystems, Applera, Courtaboeuf, France) or 'Total RNA Isolation Kit II' (Macherey Nagel, Hoerdt, France). All RNA samples were then stored at À80 1C. The quantification of RNA samples was achieved using the Nanodrop ND-1000 Spectrophotometer and the integrity of the RNA was verified using the Agilent 2100 Bioanalyzer with the Eukaryote Total RNA Nano assay. One microgram of total RNA was reverse-transcribed in a 20 ml final reaction volume using the high capacity cDNA Reverse Transcription Kit with RNase inhibitor (Applied Biosystems, Applera, Courtaboeuf, France) following the manufacturer's instructions. For the human and mouse AIF1 and AIF2, the following primers and Taqman MGB probes were custom-made by Applied Biosystems: human AIF1 primer (AIF1F): 
